Learn More
The aim of this study was to investigate whether resolvin E1 (RvE1) protects against hepatic fibrosis in a murine model of liver fibrosis induced by Schistosoma japonicum infection. A total of 30 pathogen-free Kunming mice were randomly and equally divided into three groups: Control (uninfected, untreated), model (infected, untreated) and RvE1 intervention(More)
To explore effects of the siRNA of the survivin enhanced tumor sensitivity to chemotherapeutic drugs in human pancreatic cancer cells. A siRNA expression plasmid against the survivin gene were designed, transferred into human pancreatic carcinoma cell line Panc-1 and effected on the cell cycle. After 48 hours transfected, the expression of the survivin gene(More)
To explore effects of the siRNA of the survivin enhanced tumor sensitivity to chemotherapeutic drugs in human pancreatic cancer cells. A siRNA expression plasmid against the survivin gene were designed, transferred into human pancreatic carcinoma cell line Panc-1 and effected on the cell cycle. After 48 hours transfected, the expression of the survivin gene(More)
In order to fully test the resolvins E1 pharmacodynamics in mice with acute lung injury and evaluate the influence of RvE1 on inflammatory response. 30 male Kunming mice were randomly divided into three groups, normal control group, ALI model control group and RvE1 treated group. The animal model of ALI was established by LPS intraperitoneal injection.(More)
  • 1